tiprankstipranks
Affimed Appoints New Director Amid Strategic Moves
Company Announcements

Affimed Appoints New Director Amid Strategic Moves

Affimed (AFMD) has released an update.

Pick the best stocks and maximize your portfolio:

Affimed N.V. announced at its Extraordinary General Meeting that shareholders have approved the appointment of Shawn Leland as a managing director and an addendum to the remuneration policy for the management board. This move reflects Affimed’s strategic direction and could impact its stock performance.

For further insights into AFMD stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyAffimed price target lowered to $11 from $15 at Wells Fargo
TheFlyAffimed price target lowered to $7 from $10 at H.C. Wainwright
TipRanks Auto-Generated NewsdeskAffimed’s Promising Clinical Update on NSCLC Treatment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App